In 1981, some of the most respected names in medicine asked a hopeful question in the journal Nature. People who ate more carotenoid-rich fruit and vegetables seemed to get less cancer: could beta-carotene, the orange pigment in carrots, be the reason?1 It was a fair question, so the pigment was put into capsules and tested on tens of thousands of people. What happened next is one of the great lessons in nutrition, and it explains why a naturopath looks at the whole person and the whole plate.
The capsule that backfired
In Finland, 29,133 male smokers took beta-carotene, vitamin E, both or a placebo for five to eight years. Lung cancer was 18 per cent higher among the men taking beta-carotene.2 In the United States, a trial of 18,314 smokers, former smokers and asbestos workers was stopped 21 months early: those given beta-carotene with vitamin A had 28 per cent more lung cancer and 17 per cent more deaths from any cause.3 A third trial, in 22,071 American doctors, few of whom smoked, ran for more than a decade and found almost no difference in either direction.4
So an isolated nutrient, given in large daily amounts for years, did nothing for the healthiest group and harm in those whose lungs were already under attack. Laboratory work offers a clue as to why. Ferrets given high-dose beta-carotene and exposed to smoke developed abnormal growth in their lung tissue, along with falling levels of the vitamin A signal that keeps those cells in order.5 The same nutrient, in a different body and a different amount, behaved quite differently.
It was not a one-off. When trials of antioxidant supplements were pooled, the better-run ones linked beta-carotene, vitamin A and vitamin E with a small rise in deaths.6 A trial of more than 35,000 men found 17 per cent more prostate cancer with vitamin E capsules.7 None of this says that carrots are dangerous, or that a supplement can never help. Targeted nutrients have a real place where a body is truly short of something. It says that a nutrient lifted out of its food, and given to everyone alike, is a different proposition from the food itself.
A nutrient in a capsule is not the same thing as a nutrient in a meal.
Food is more than its parts
Researchers now have a name for this: food synergy. The constituents of a food come coordinated and buffered, in balance with one another, and they meet the gut and the body together. The evidence for benefit grows stronger as we move from isolated compounds to foods and then to whole patterns of eating.8 A few examples show how it works.
- The apple. In a test-tube assay, 100 g of fresh apple with its skin had the antioxidant activity of around 1,500 mg of vitamin C, although it holds only a few milligrams of the vitamin itself. Most of that activity came from the rest of the fruit.9 A test tube is not a body, but it shows how little of a food one headline nutrient can explain.
- The sprout and the pill. Broccoli sprouts carry their own enzyme, myrosinase, which helps release sulphoraphane. When 12 volunteers ate fresh sprouts and later took a broccoli supplement with no active enzyme, far less sulphoraphane reached their blood from the pills.10
- The salad and its dressing. Carotenoids dissolve in fat. When volunteers ate a colourful salad with a fat-free dressing, almost none of the carotenoids could be detected in the fat-carrying particles of their blood; as the dressing's fat went up, so did absorption.11 The principle is everyday kitchen wisdom: a little olive oil on the salad earns its place.
- The whole diet. In the PREDIMED trial of 7,447 people at high risk of heart disease, a Mediterranean way of eating with extra virgin olive oil or nuts brought around 30 per cent fewer heart attacks, strokes and heart-related deaths than a low-fat diet.12 It was the whole pattern that was tested, rather than any one ingredient.
- The partnership. In Oxford's VITACOG trial, B vitamins slowed brain shrinkage only in people with good omega-3 levels.13 Study either one alone and the benefit could have been missed (see Tipping the Balance).
Herbalists have worked this way for centuries. A plant contains hundreds of compounds, and one may ease the absorption of another or act on a different target in the same pathway; this is why researchers have turned to studying the synergy of whole extracts rather than single constituents.14 It is also why the right herb depends on the person. Herbs are best chosen to suit your constitution, with a practitioner's guidance rather than self-prescribing.
One symptom, one number
The same trap waits when we study one symptom alone. For much of the twentieth century, stomach ulcers were put down to stress and excess acid, and treatment centred on calming the acid. Then an Australian pathologist, Robin Warren, and a young doctor, Barry Marshall, looked closely at biopsies from 100 consecutive patients and found curved bacteria in 58 of them, including almost everyone with an active ulcer or gastritis.15 When few would believe it, Marshall swallowed a culture of the organism and developed gastritis within ten days.16 The pair shared the 2005 Nobel Prize. Careful observation of real patients had asked the question that symptom relief had left unasked: why is this happening?
Averages can hide the person too. In a small double-blind trial of pomegranate extract, cholesterol fell only in people whose gut bacteria produced a particular pattern of compounds, called urolithins.17 Pooled together, responders and non-responders blur into one modest number. Add your history, your digestion, your stress and your sleep, and the answer to "does this work?" often becomes "for whom, and when?"
What observation adds
Some of the most important facts in medicine were never tested in a randomised trial, and never could be. No ethics committee would assign people to smoke for thirty years. Doll and Hill built the case from careful observation: a study of hospital patients in London in 1950, followed by decades of consistent findings across many populations.18 That observational evidence is complex because life is complex, and it reflects the difficulty of the subject rather than any lack of truth.
Case reports do something else that a trial cannot. They are the sharpest tool we have for spotting the new and unexpected, including new diseases and unforeseen effects of treatment, good and bad.19 Larger comparisons are reassuring here too: a 2024 Cochrane review of 47 evidence reviews found that, on average, observational studies and randomised trials of the same question reached similar answers, with little or no difference overall.20
The clinic as a place of learning
Every practice holds a quiet store of evidence. Clinical audit, a routine part of good NHS care, means measuring what we do against clear standards, changing what falls short and checking again.21 In a natural health clinic, that can mean gathering the notes of everyone who came with irritable bowel and asking honestly: what changed, for whom, and what did we miss?
Tools exist to do this well. MYMOP, developed by a British researcher and tested in NHS general practice and complementary clinics, asks people to name the problems that matter most to them, in their own words, and score them over time. It picked up change far more sensitively than a standard health survey.22 That is a small revolution: the person, rather than the researcher, decides what counts as getting better.
Each method has its job, and none does every job:
- A controlled trial asks whether this one thing, on average, makes a difference. It is how the harm from beta-carotene capsules came to light.
- Population studies ask what happens over years of real life, as they did with smoking, and with colourful vegetables.
- Case studies show one person in full, and spot what nobody thought to look for.
- Clinical audit and outcome measures show what is happening to real people in a real practice. They can't tell us what would have happened anyway, since many problems ease with time, so they are read alongside the rest.
Return to beta-carotene and every part of the story falls into place. Observation noticed that people who ate colourful plants did well. Trials showed that the capsule was not the plant. Neither was wrong. They were answering different questions, and the mistake lay in assuming that the answer to one settled the other.
Bringing it home
- Eat the food first. Aim for 30 different plants a week, in every colour, with their skins where you can.
- Think in meals. Pair vegetables with a little olive oil, protein and something fermented, rather than chasing a single star ingredient.
- Be wary of "the nutrient that". When a capsule borrows its reputation from a food, ask whether the capsule itself has been tested.
- Keep your own record. Note what you change, and how you sleep, feel and digest. Your response is real evidence about you.
- Have supplements chosen for you. Whether you take one should rest on your own requirements and tests, not on a label. If you smoke or have worked with asbestos and take beta-carotene, please seek advice from a qualified practitioner.
In short
- Beta-carotene capsules raised lung cancer in smokers and asbestos workers, even though people eating carotenoid-rich plants do well.
- Foods work as coordinated wholes: their parts help one another, and the benefit grows from nutrient to food to whole diet.
- Studying one symptom or one average can miss the cause, and can miss the person who responds.
- Observation, case studies and clinical audit see what trials can't, and trials test what observation can't. We need them all.
At Rootwise, we begin with the whole picture: your story, your food, your digestion, your stress and your sleep, with tests where they help. If you would like to understand what your own body is asking for, we would love to explore it with you in a consultation.
References
- Peto R et al. Can dietary beta-carotene materially reduce human cancer rates? Nature, 1981.
- Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. New England Journal of Medicine, 1994.
- Omenn GS et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. New England Journal of Medicine, 1996.
- Hennekens CH et al. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. New England Journal of Medicine, 1996.
- Wang XD et al. Retinoid signaling and activator protein-1 expression in ferrets given beta-carotene supplements and exposed to tobacco smoke. Journal of the National Cancer Institute, 1999.
- Bjelakovic G et al. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA, 2007.
- Klein EA et al. Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA, 2011.
- Jacobs DR, Gross MD, Tapsell LC. Food synergy: an operational concept for understanding nutrition. American Journal of Clinical Nutrition, 2009.
- Eberhardt MV, Lee CY, Liu RH. Antioxidant activity of fresh apples. Nature, 2000.
- Clarke JD et al. Bioavailability and inter-conversion of sulforaphane and erucin in human subjects consuming broccoli sprouts or broccoli supplement in a cross-over study design. Pharmacological Research, 2011.
- Brown MJ et al. Carotenoid bioavailability is higher from salads ingested with full-fat than with fat-reduced salad dressings as measured with electrochemical detection. American Journal of Clinical Nutrition, 2004.
- Estruch R et al. Primary prevention of cardiovascular disease with a Mediterranean diet supplemented with extra-virgin olive oil or nuts. New England Journal of Medicine, 2018.
- Jernerén F et al. Brain atrophy in cognitively impaired elderly: the importance of long-chain ω-3 fatty acids and B vitamin status in a randomized controlled trial. American Journal of Clinical Nutrition, 2015.
- Wagner H, Ulrich-Merzenich G. Synergy research: approaching a new generation of phytopharmaceuticals. Phytomedicine, 2009.
- Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. The Lancet, 1984.
- Marshall BJ et al. Attempt to fulfil Koch's postulates for pyloric Campylobacter. Medical Journal of Australia, 1985.
- González-Sarrías A et al. Clustering according to urolithin metabotype explains the interindividual variability in the improvement of cardiovascular risk biomarkers in overweight-obese individuals consuming pomegranate: a randomized clinical trial. Molecular Nutrition & Food Research, 2017.
- Doll R, Hill AB. Smoking and carcinoma of the lung: preliminary report. BMJ, 1950.
- Vandenbroucke JP. In defense of case reports and case series. Annals of Internal Medicine, 2001.
- Toews I et al. Healthcare outcomes assessed with observational study designs compared with those assessed in randomized trials: a meta-epidemiological study. Cochrane Database of Systematic Reviews, 2024.
- Healthcare Quality Improvement Partnership. Best Practice in Clinical Audit. HQIP, 2016.
- Paterson C. Measuring outcomes in primary care: a patient generated measure, MYMOP, compared with the SF-36 health survey. BMJ, 1996.
This article is for general information and isn't a substitute for personal advice. If you take prescribed medicines, never stop or change them without your prescriber, and check any herbs or supplements with your GP or pharmacist.